Biogen’s Aduhelm Sales Total $2 Million in Second Quarter July 22, 2021 Auto Bot Aduhelm (Drug), alzheimer's disease, Biogen Inc, Food and Drug Administration, Health Insurance and Managed Care, Medicare, Vounatsos, Michel 0 The drug from Biogen, called Aduhelm, is expected to generate billions in sales. It could also strain Medicare’s budget within a few years.